• 1
    Hotamisligil, G. S. (1999) The role of TNFalpha and TNF receptors in obesity and insulin resistance. J Intern Med. 245: 621625.
  • 2
    Peraldi, P., Spiegelman, B. M. (1997) Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-alpha. J Endocrinol. 155: 219220.
  • 3
    Miyazaki, Y., Pipek, R., Mandarino, L. J., De Fronzo, R. A. (2003) Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. Int J Obes Relat Metab Disord. J27: 8894.
  • 4
    Fliers, J. S. (2001) Diabetes: the missing link with obesity? Nature. 18: 292293.
  • 5
    Hotamisligil, G. S. (1999) Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol. 107: 119125.
  • 6
    Hube, F., Hauner, H. (1999) The role of TNF-alpha in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm Metab Res. 31: 626631.
  • 7
    Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., Kern, P. A. (1996) The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest. 15:97: 11111116.
  • 8
    Knight, D. M., Trinh, H., Le, J., et al (1993) Construction and initial characterization of a mouse-human chimeric anti-TNF antibody. Molec Immunol. 30: 14431453.
  • 9
    Hotamisligil, G. S., Budavari, A., Murray, D., Spiegelman, B. M. (1994) Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes.Central role of tumor necrosis factor-alpha. J Clin Invest. 94: 15431549.
  • 10
    Hotamisligil, G. S., Shargill, N. S., Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259: 8791.
  • 11
    Ofei, F., Hurel, S., Newkirk, J., Sopwith, M., Taylor, R. (1996) Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in petients with NIDDM. Diabetes. 45: 881885.
  • 12
    Paquot, N., Castillo, M. J., Lefebvre, P. J., Scheen, A. J. (2000) No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin resistant patients. J Clin Endocrinol Metab. 85: 13161319.
  • 13
    Moore, F. D., Olesen, K. H., McMurrey, J. D., Parker, H. V., Ball, M. R., Boyden, C. M. (1963) The Body Cell Mass and Its Supporting Environment. Saunders: Philadelphia, PA.
  • 14
    Culebras, J. M., Moore, F. D. (1977) Total body water and the exchangeable hydrogen I. Theoretical calculations of nonaqueous exchangeable hydrogen in men. Am J Physiol. 232: R54R59.
  • 15
    Heymsfield, S. B., Lichtman, S., Baumgartner, R. N., et al (1990) Body composition of humans: comparison of two improved four-compartment models that differ in expense, technical complexity, and radiation exposure. Am J Clin Nutr. 52: 5258.
  • 16
    DeFronzo, R. A., Tobin, J. D., Anders, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237: 214223.
  • 17
    Scallon, B. J., Moore, M. A., Trinh, H., Knight, D. M., Ghrayeb, J. (1995) Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine. 7: 251259.
  • 18
    Cope, A. P., Londei, M., Chu, N. R., et al (1994) Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest. 94: 749760.
  • 19
    Hauner, H., Bender, M., Haastert, B., Hube, F. (1998) Plasma concentration of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord. 22: 12391243.
  • 20
    Dzienis-Straczkowska, S., Straczkowski, M., Szelachowska, M., Stepien, A., Kowalska, I., Kinalska, I. (2003) Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care. 26: 875880.
  • 21
    Straczkowski, M., Kowalska, I., Dzienis-Straczkowska, S., et al (2001) Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur J Endocrinol. 14: 273280.
  • 22
    Fernandez-Real, J. M., Broch, M., Ricart, W., et al (1998) Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes. 47: 17571762.
  • 23
    Bastard, J. P., Jardel, C., Bruckert, E., Vidal, H., Hainque, B. (2000) Variations in plasma soluble tumor necrosis factor receptors after diet-induced weight loss in obesity. Diabetes Obes Metab. 2: 323325.
  • 24
    Bullo, M., Garcia-Lorda, P., Salas-Salvado, J. (2000) Plasma soluble tumor necrosis factor alpha receptors and leptin levels in normal weight and obese women: effect of adiposity and diabetes. Eur J Endocrinol. 146: 325331.
  • 25
    Mingrone, G., Rosa, G., Di Rocco, P., et al (2002) Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord. 26: 11651172.